How the Uterine Fibroid Embolization Device Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the Uterine Fibroid Embolization Device Market?
The uptick in demand for minimally invasive surgical procedures is predicted to boost the growth of the uterine fibroid embolization device market. Minimally invasive surgeries involve operating through small incisions or natural body orifices, facilitating a lesser degree of bodily trauma. The role of uterine fibroid embolization devices in these types of surgeries is crucial as they allow effective treatment of uterine fibroids with reduced invasiveness and minimal collateral impact on adjacent tissues. Consequently, these types of surgeries are gaining traction, contributing to improved patient outcomes. For instance, data from The Aesthetic Society (a US-based organization of plastic surgery and cosmetic medicine) in August 2023 documented that Americans spent over $11.8 billion on aesthetic procedures, marking a 2% increase from prior year records. Thus, the market for uterine fibroid embolization devices is benefiting from the rising demand for such surgeries. Rise in Aging Population Fuels Growth of Uterine Fibroid Embolization Device Market
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13551&type=smp
#What is the Projected CAGR for the Uterine Fibroid Embolization Device Market Size from 2025 to 2034?
In recent times, the market size for uterine fibroid embolization devices has seen robust growth. It is projected to grow from a value of $5.62 billion in 2024 to a worth of $5.93 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the historic period include an increasing occurrence of uterine fibroids, a preference for non-surgical alternatives, initiatives on awareness and education, a greater emphasis on women’s health, a transition towards outpatient procedures, and programs training physicians.
The market for uterine fibroid embolization devices is projected to experience consistent expansion in the forthcoming years, reaching a value of $7.04 billion in 2029 with a compound annual growth rate of 4.4%. The imminent growth within the forecast period can be associated with an uptick in the awareness about non-invasive therapies, worldwide growth of healthcare facilities, improvements in women’s health programs, collaboration with multi-specialty care, and the growth of outpatient services. The overall forecast period will be marked by key trends such as the rise in the usage of minimally invasive techniques, progression in embolic agents, customized treatment strategies, emphasis on outpatient ufe procedures, combination of imaging technologies, and research into bioresorbable embolic agents.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13551
What Are the Most Significant Market Trends Transforming theUterine Fibroid Embolization Device Market?
Leading firms in the uterine fibroid embolization device market like Medtronic Private Limited are creating ground-breaking products such as the TruClear system to cater to the rising demand for less invasive uterine fibroid treatments, and to enhance the safety and effectiveness of said treatments. The TruClear mechanism, a mechanical hysteroscopic tissue extraction system, addresses intrauterine irregularities (IUA). It’s a flexible catheter inserted into the uterus via the cervix. In November 2022, Medtronic, an industrial medical equipment manufacturer located in India, introduced this novel TruClear system. It offers a safe and effective solution for treating IUA, with its easy-to-use, flexible catheter built with a revolving nitinol wire loop, continuous inflow, and outflow, integrated suction, and advanced imaging capabilities. This greatly improves the accuracy and safety of the procedures used to treat uterine fibroids.
What Are the Top Market Players Propelling the Growth of theUterine Fibroid Embolization Device Industry?
Major companies operating in the uterine fibroid embolization device market report are Johnson and Johnson Pvt Ltd., Abbott Laboratories, Medtronic plc., Siemens Healthineers Ltd., Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, GE HealthCare Technologies Inc., Olympus Corporation, Terumo Corporation, Smith and Nephew plc., Ethicon Inc., Hologic Inc., CooperSurgical Inc., Ferring B.V., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Amsino International Inc., Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd., INSIGHTEC Ltd., Hironic Co.Ltd., Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC, Hitachi Medical Corporation
Order Your Report Now For A Swift Delivery:
Which Primary Segments of the Uterine Fibroid Embolization Device Market Are Driving Growth and Industry Transformations?
The uterine fibroid embolization device market covered in this report is segmented –
1) By Technology: Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Techniques
2) By Mode Of Treatment: Invasive Treatment, Minimally Invasive Treatment, Non-Invasive Treatment
3) By End User: Hospitals, Clinics, Ambulatory Surgical Center
Subsegments:
1) By Surgical Techniques: Open Surgery, Myomectomy
2) By Laparoscopic Techniques: Laparoscopic Myomectomy, Laparoscopic Hysterectomy
3) By Ablation Techniques: Radiofrequency Ablation, Microwave Ablation, Cryoablation
4) By Embolization Techniques: Transcatheter Arterial Embolization (TAE), Uterine Artery Embolization (UAE)
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13551&type=smp
Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Uterine Fibroid Embolization Device Market?# Market?
North America was the largest region in the uterine fibroid embolization device market in 2024. The regions covered in the uterine fibroid embolization device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Uterine Fibroid Embolization Device Market 2025, By The Business Research Company:
Magnetic Resonance Imaging Systems Devices And Equipment Global Market Report 2024
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2024
Lancing Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/lancing-devices-and-equipment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
